AGM
RVPH

Alpine Global Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Alpine Global Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,210
Closed -$690K – 395
2020
Q2 		$690K Buy
+3,210
New +$684K 0.12% 117

Other funds holding RVPH

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $2.18B AUM 13.58% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $469M AUM 32.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Alpine Global Management's RVPH Position: Q3 2020 in Review

Alpine Global Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q3 2020, closing a stake of 3,210 shares — an estimated $690K sold.

Alpine Global Management first reported a position in RVPH in Q2 2020 and held it in 1 quarter. The position peaked at $690K in Q2 2020. 13 funds tracked by Wall St. Rank hold RVPH as of Q3 2020.

  • Alpine Global Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q3 2020 after selling out during the quarter.
  • Alpine Global Management sold 3,210 REVIVA PHARMA HLDGS INC shares in Q3 2020, an estimated $690K.
  • Alpine Global Management first reported a position in REVIVA PHARMA HLDGS INC in Q2 2020 and held it in 1 quarter.
  • Alpine Global Management's REVIVA PHARMA HLDGS INC position peaked at $690K in Q2 2020.
  • 13 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q3 2020.

Based on Alpine Global Management's 13F filing for Q3 2020, filed 12 Nov 2020.